ישראל - עברית - Ministry of Health

rafa laboratories ltd - sulpiride - קפסולות - sulpiride 50 mg - sulpiride - sulpiride - anti - dopaminergic agent for use in peptic ulcer and vomiting vertigo prepsychotic states.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - sulpiride - טבליה - sulpiride 200 mg - sulpiride - sulpiride - anti - dopaminergic agent. 1) for use in peptic ulcer and vomiting vertigo prepsychotic states. 2) at high doses - in psychiatric patients for treatment of depression and apathy.

ישראל - עברית - Ministry of Health

eliezer linevitz ltd. - marbofloxacin - תמיסה להזרקה - marbofloxacin 100 mg/ml - in cattle: treatment of respiratory infections caused by sensitive strains of pasteurella multocida, pasteurella haemolytica bovis. in sows: treatment of metritis mastitis agalactia syndrome caused by bacterial strains sensitive to marbofloxacin treatment in both species should be given only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).

ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - cefovicin as sodium salt - אבקה וממס להכנת תמיסה להזרקה - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.

ישראל - עברית - Ministry of Health

intervet ( israel) ltd - florfenicol; flunixin meglumine - תמיסה להזרקה - florfenicol 300 mg/ml; flunixin meglumine 27.4 mg/ml - therapeutic treatment of febrile respiratory tract infections caused by mannheimia haemolytica , pasteurella multocida or histophilus somni in cattle.

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

ישראל - עברית - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

ישראל - עברית - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

ישראל - עברית - Ministry of Health

novartis pharma services ag - clozapine 25 mg - tablets - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.

ישראל - עברית - Ministry of Health

novartis pharma services ag - clozapine 100 mg - tablets - diazepines, oxazepines, thiazepines and oxepines - for treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for diath.